NEO logo

NEO
Neogenomics Inc.

2,871
Mkt Cap
$1.08B
Volume
2,588.00
52W High
$13.74
52W Low
$4.72
PE Ratio
-10.82
NEO Fundamentals
Price
$8.36
Prev Close
$8.26
Open
$8.29
50D MA
$8.32
Beta
1.36
Avg. Volume
2.67M
EPS (Annual)
-$0.8433
P/B
1.31
Rev/Employee
$290,932.80
$1,756.31
Loading...
Loading...
News
all
press releases
TD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock Price
TD Cowen boosted their target price on shares of NeoGenomics from $13.00 to $14.00 and gave the company a "buy" rating in a research note on Wednesday...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
NeoGenomics (NASDAQ:NEO) Shares Gap Up Following Analyst Upgrade
NeoGenomics (NASDAQ:NEO) Shares Gap Up on Analyst Upgrade...
MarketBeat·16d ago
News Placeholder
Wall Street’s Next Biotech Winners Emerge as FDA Acceleration Unleashes New Markets
The biotech and health-tech landscape is entering a new acceleration phase, driven by regulatory momentum, AI integration, and a surge in precision medicine. $NEO, $TGNT, $XTLB, $SAGT, $PRCH, $AKAN
24-7 Market News·16d ago
News Placeholder
NeoGenomics (NASDAQ:NEO) Upgraded by Leerink Partners to Outperform Rating
Leerink Partners upgraded NeoGenomics from a "market perform" rating to an "outperform" rating and increased their target price for the company from $12.00 to $25.00 in a research report on Wednesday...
MarketBeat·16d ago
News Placeholder
NeoGenomics (NASDAQ:NEO) Announces Quarterly Earnings Results, Hits Estimates
NeoGenomics (NASDAQ:NEO - Get Free Report) released its earnings results on Tuesday. The medical research company reported $0.01 earnings per share for the quarter, meeting analysts' consensus...
MarketBeat·16d ago
News Placeholder
NeoGenomics Q1 Earnings Call Highlights
NeoGenomics (NASDAQ:NEO) reported first-quarter 2026 results that management said reflected continued momentum in its clinical business and growing contributions from newer, higher-value oncology...
MarketBeat·17d ago
News Placeholder
NeoGenomics (NEO) Q1 2026 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·17d ago
News Placeholder
NeoGenomics (NEO) Q1 2025 Earnings Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·17d ago
News Placeholder
NeoGenomics Reports First Quarter 2026 Results
NeoGenomics, Inc. (NASDAQ: NEO) (the Company), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its first quarter results for the period ended March...
Business Wire·17d ago
News Placeholder
NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that its oncology testing portfolio is now available through Epic...
Business Wire·22d ago
<
1
2
...
>

Latest NEO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.